These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, Richens A, Stern RS, Trevathan E. Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224 [Abstract] [Full Text] [Related]
34. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents. Mazurkiewicz-Bełdzińska M, Szmuda M, Matheisel A. Seizure; 2010 Apr; 19(3):195-7. PubMed ID: 20167512 [Abstract] [Full Text] [Related]
35. Lupus anticoagulant induced by the combination of valproate and lamotrigine. Echaniz-Laguna A, Thiriaux A, Ruolt-Olivesi I, Marescaux C, Hirsch E. Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597 [Abstract] [Full Text] [Related]
36. Drug treatment of epilepsy in elderly people: focus on valproic Acid. Stephen LJ. Drugs Aging; 2003 Nov; 20(2):141-52. PubMed ID: 12534314 [Abstract] [Full Text] [Related]
38. Effect of comedication on lamotrigine clearance in Korean epilepsy patients. Kim HJ, Kim TE, Joo EY, Seo DW, Lee SY, Hong SB. Clin Chim Acta; 2015 Jan 01; 438():269-73. PubMed ID: 25218785 [Abstract] [Full Text] [Related]